InsiderTrades

SANDS FRANK M.

SEC CIK 1870494 · EDGAR

Buying vs selling by month open-market trades, last 60 months, all 2 companies
BoughtSold

Companies

TickerCompanyTitleHoldingBoughtSoldTradesFirstLast
IKTInhibikase Therapeutics, Inc.10% 13.02M $3.00M — 12025-11-212025-11-21
ABOSAcumen Pharmaceuticals, Inc.10% 1.12M $6.70M — 22021-07-062021-07-06

Most active insiders at IKT, 12 months

#InsiderTitleBoughtSold
1 SANDS FRANK M.10% $3.00M—
2 Cabell ChristopherPres, Head of R, D ——
3 Aurentz VincentDir ——
4 Munshi AmitDir ——
5 RA CAPITAL MANAGEMENT, L.P.10% ——
6 BERMAN DENNIS NDir ——

Transactions 3

Type
Reset
X Filed Traded Ticker Company Insider Title Type Price Qty Owned ΔOwn Value
2025-11-24 2025-11-21 IKT Inhibikase Therapeutics, Inc. SANDS FRANK M. 10% P - Purchase $1.45 +2.07M 13.02M +19% +$3.00M
DM 2021-07-08 2021-07-06 ABOS Acumen Pharmaceuticals, Inc. SANDS FRANK M. 10% C - Cnv Deriv — +2.97M 1.12M New —
D 2021-07-08 2021-07-06 ABOS Acumen Pharmaceuticals, Inc. SANDS FRANK M. 10% P - Purchase $14.88 +450.0K 3.42M +15% +$6.70M

Purchase Sale Sale after option exercise All abbreviations